Perflubron
Generic Name: perflubron
Manufactured by ALLIANCE PHARM. Dosage form: LIQUID. Route: ORAL. Active ingredients: PERFLUBRON (100%). Application: NDA020091.
Overview
Manufactured by ALLIANCE PHARM. Dosage form: LIQUID. Route: ORAL. Active ingredients: PERFLUBRON (100%). Application: NDA020091.
Dosage
Available as liquid for oral use.
Related Medications
Coagulation Factor Viia (recombinant)
coagulation factor viia (recombinant)
Dosage form: KIT. Category: BLA.
Chlormezanone
chlormezanone
Manufactured by SANOFI AVENTIS US. Dosage form: TABLET. Route: ORAL. Active ingredients: CHLORMEZANONE (100MG). Application: NDA011467.
Maraviroc
maraviroc
CCR5 Co-receptor Antagonist [EPC]
11 DESCRIPTION Maraviroc is a selective, slowly reversible, small molecule antagonist of the interaction between human CCR5 and HIV-1 gp120. Blocking this interaction prevents CCR5-tropic HIV-1 entry into cells. Maraviroc film-coated tablets for oral administration contain 150, or 300 mg of maraviroc and the following inactive ingredients: anhydrous dibasic calcium phosphate, hydroxypropyl methyl cellulose, magnesium stearate, microcrystalline cellulose, and sodium starch glycolate.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.